Fieldpoint Private Securities’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-45
Closed -$1K 1699
2022
Q1
$1K Hold
45
﹤0.01% 1616
2021
Q4
$1K Hold
45
﹤0.01% 1606
2021
Q3
$1K Hold
45
﹤0.01% 1606
2021
Q2
$1K Hold
45
﹤0.01% 1519
2021
Q1
$1K Buy
+45
New +$923 ﹤0.01% 1524

Other funds holding TBI

Fieldpoint Private Securities's TBI Position: Q2 2022 in Review

Fieldpoint Private Securities sold out of Trueblue (TBI) in Q2 2022, closing a stake of 45 shares — an estimated $1K sold.

Fieldpoint Private Securities first reported a position in TBI in Q1 2021 and held it in 5 quarters. The position peaked at $1K in Q1 2022. 173 funds tracked by Wall St. Rank hold TBI as of Q2 2022.

  • Fieldpoint Private Securities reported no remaining Trueblue position as of Q2 2022 after selling out during the quarter.
  • Fieldpoint Private Securities sold 45 Trueblue shares in Q2 2022, an estimated $1K.
  • Fieldpoint Private Securities first reported a position in Trueblue in Q1 2021 and held it in 5 quarters.
  • Fieldpoint Private Securities's Trueblue position peaked at $1K in Q1 2022.
  • 173 funds tracked by Wall St. Rank held Trueblue as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.